跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DUMIN SYRUP 120MG/5ML - HSA Drug Approval Details
Approvals
/
HSA
/
DUMIN SYRUP 120MG/5ML
Approved
THERAPEUTIC
DUMIN SYRUP 120MG/5ML
PT Actavis Indonesia
🇸🇬 Health Sciences Authority
Approval Date
Mar 21, 2017
Approval ID
7846f4419cb4cccc
Company
PT Actavis Indonesia
Type
Therapeutic
Approval Details
Approval Id
7846f4419cb4cccc
Drug Name
DUMIN SYRUP 120MG/5ML
Product Name
DUMIN SYRUP 120MG/5ML
Approval Number
SIN15196P
Approval Date
2017-03-21
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
N02BE01
Atc Item Name
paracetamol
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Paracetamol
120mg/5ml
PARACETAMOL
120 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 21, 2017
Approval ID
7846f4419cb4cccc
Type
Therapeutic
Back to HSA Approvals